FDA Notification: Tianeptine Products Linked to Serious Harm, Overdoses, Death

Medication SafetySubstance use disorderHealthcare ProfessionalEducators and caregivers

Feb 11

Written by Denise Kolakowski

Tianeptine Sulfate

Learn more from the FDA

Denise Kolakowski

FDA Investigation of Cronobacter and Salmonella Complaints: Powdered Infant Formula (February 2022)

FDA Takes Steps Aimed at Fostering Development of Non-Addictive Alternatives to Opioids for Acute Pain Management